Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Pharm Biomed Anal. 2012 Jan 14;69:93–105. doi: 10.1016/j.jpba.2012.01.004

Figure 8.

Figure 8

Examples of (a) a zonal elution competition study with R-warfarin and gliclazide as a competing agent on an HSA column and (b) a frontal analysis experiment for gliclazide applied to an HSA column, with data being fitted to a two-site binding model. Terms: k, retention factor; mL,app, moles of applied target that are needed to reach the mean position of the breakthrough curve at a given concentration of the target. Adapted with permission from Ref. [121].